CareSens Air
i-SENS
What it is
A 15-day standalone CGM sold in Australia for adults with diabetes. Current manufacturer specifications describe optional calibration and a 30-minute warm-up; the supplied regional manual takes precedence.
Editorial review: . What was checked and what remains uncertain.
Source dates appear in the references where available; this record has no dated citation metadata.
Trial status, labels and access can change between reviews.
Evidence behind this assessment
Key evidence notes. Study results, product eligibility and access answer different questions.
- Who was studied?
- Study populations and analysis groups vary. Product age limits alone do not describe who was studied.
- Benefit or performance
- Accuracy: Conservative editorial assessment; no comparative T1D accuracy result verified here.[1]
- Important harms and treatment burden
- Read the safety discussion and original sources. A missing summary does not establish safety.
- Approval and country access
- Country-specific approval and access are not summarized in this record.Approval, trial recruitment, local supply and funding are separate. Check the cited label or access source.
- Follow-up and remaining uncertainty
- Read the record-specific review limits for gaps in evidence, source access or availability checks.
This record cites company or conference reports. Those sources may describe interim findings; their source type is shown in the source list.
Editorial score: calculation and evidence
A weighted editorial judgment on a 0–100 scale, not a probability of success or a measured treatment effect. Higher criterion scores mean more favorable assessments.
Default calculation: 45 × 20 + 40 × 15 + 10 × 15 + 88 × 10 + 88 × 10 + 60 × 10 + 80 × 10 + 0 × 5 + 60 × 5 = 5110; divide by total weight 100. Unrounded weighted result: 51.1.
Current product supports optional calibration; check the supplied local instructions.[1]
Editor’s take
Scores are editorial judgments about the evidence and practical features, not measured comparative performance or a probability of success.
The full picture
CareSens Air provides glucose readings every five minutes. The manufacturer lists 15-day wear, a 30-minute warm-up and a 5 mm, 4.5 g sensor, with calibration available when readings seem unusual.1
Pharmaco sells it in Australia for people with type 1 or type 2 diabetes aged 18 and over. The Australian manual excludes use in children, pregnancy, breastfeeding, dialysis and critical illness. Check blood glucose when readings do not match symptoms or expectations.23 ARTG496627 confirms an I-Sens CGM registration sponsored by Pharmaco, but the register entry itself does not identify a retail model.4
No commercial AID integration or independently verified comparative accuracy result is established by these sources. This record does not infer NDSS funding or nationwide pharmacy stock. CareSens Air 2 is a separate announced successor.
References
-
CareSens Air current specifications. https://i-sens.com/products/caresens-air/ ↩
-
Pharmaco Australia CareSens Air product and safety information. https://pharmacodiabetes.com.au/products/caresens-air ↩
-
Australian CareSens Air instructions. https://cdn.shopify.com/s/files/1/0991/7127/1021/files/caresens-air-user-manual.pdf?v=1776984388 ↩
-
TGA ARTG496627, I-Sens CGM sponsored by Pharmaco. https://www.tga.gov.au/resources/artg/496627 ↩
Sources
- [1]CareSens Air current specifications · manufacturer
- [2]Pharmaco Australia CareSens Air product and safety information · manufacturer
- [3]TGA ARTG496627, I-Sens CGM sponsored by Pharmaco · regulatory
- [4]Australian CareSens Air instructions · manufacturer — Current PDF linked by the official Pharmaco Australia product page. Downloaded and inspected 16 September 2026: page 12 confirms adult 18+ indication and excluded populations; page 53 confirms 30-minute warm-up; page 106 describes optional calibration.